Efficacy and safety of fexapotide triflutate in outpatient medical treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia

Male lower urinary tract symptoms (LUTS) is an increasingly important problem for the majority of late middle aged and elderly men. Fexapotide triflutate (FT) is a first in-class compound given by local injection via the transrectal intraprostatic route under ultrasound guidance. Data from >1700...

ver descrição completa

Detalhes bibliográficos
Main Authors: Neal Shore, Ronald Tutrone, Claus G. Roehrborn
Formato: Artigo
Idioma:English
Publicado em: SAGE Publishing 2019-01-01
Colecção:Therapeutic Advances in Urology
Acesso em linha:https://doi.org/10.1177/1756287218820807